3sbio Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares 3sbio Inc with three other
companies in this sector in China:
Zhangzhou Pientzehuang Pharmaceutical Ltd
(2017
sales of 3.71 billion Chinese Renmimbi [US$589.89 million]
of which 51%
was Pharmaceutical Business),
Sunflower Pharmaceutical Group Co Ltd
(3.85 billion Chinese Renmimbi [US$612.25 million]
of which 98%
was Medicine), and
Tianjin Chase Sun Pharmaceutical Company Limited
(3.37 billion Chinese Renmimbi [US$535.89 million]
of which 52%
was Granules).
Sales Analysis.
3sbio Inc reported sales of 3.73 billion Chinese Renmimbi (US$593.12 million)
for the
year ending
December of 2017.
This
represents
an
increase of 33.5%
versus 2016, when the company's sales were 2.80 billion Chinese Renmimbi.
Sales at 3sbio Inc have increased during each of the previous five years
(and since 2012, sales have increased a total of 457%).